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ORIGINAL
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Abstract : To predict occult nodal metastasis in clinical N0 patients with tongue cancer, we developed combined 
index (CI) : SUVmax of the largest lymph node in PET / CT by weighting coefficient plus its maximum minor axis 
(< 10 mm) in contrast-enhanced CT (CECT). In this retrospective study, 57 clinical N0 patients with tongue can-
cer, who underwent elective supraomohyoid neck dissection at cervical levels of I-III were enrolled. The cutoff 
value of SUVmax of 2.0 obtained using receiver operating characteristic (ROC) analysis predicted the postopera-
tive positive cervical levels containing metastatic lymph nodes from clinical N0 cervical levels in tongue cancer 
patients with a sensitivity of 54.5% and a specificity of 78.2%. The cutoff value of CI with weighting coefficient of 
1.5 obtained using ROC analysis was 9.8 at the maximum area under the curve of 0.750. The cutoff value of 9.8 
predicted the postoperative positive cervical levels containing metastatic lymph nodes from clinical N0 cervical 
levels in tongue cancer patients with a sensitivity of 68.2% and a specificity of 81.5%. These findings suggest that 
CI of functional PET / CT and morphological CECT components might improve the diagnostic performance of 
occult nodal metastasis to select clinical N0 patients with tongue cancer preferable for elective neck dissection. 
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INTRODUCTION
 
Cervical lymph node metastasis is one of the most important 
prognostic factors in patients with head and neck squamous cell 
carcinoma (HNSCC) and is essential for staging procedures and 
deciding definitive treatments (1). Contrast-enhanced computed 
tomography (CECT) and magnetic resonance imaging (MRI) 
are widely used for the assessment of cervical lymph node status 
before treatment (2). However, because of false negative nodal 
metastasis assessed with CECT and MRI, the diagnostic ac-
curacy of radiological imaging modalities for detecting cervical 
lymph node metastasis is insufficient (3).  In particular, occult 
metastatic lymph nodes are the major prognostic factor for sur-
vival in HNSCC patients with clinically negative cervical lymph 
nodes (4). It was reported that the prevalence of occult metastatic 
lymph nodes was 20%–30% of HNSCC patients, regardless of 
their primary tumor T stage (5-8). 
The uptake of 18F-fluorodeoxyglucose (FDG) is increased in 
malignant tumors that enhances the metabolism of glucose. 
Therefore, positron emission tomography with integrated com-
puterized tomography (PET / CT) can assess the primary site of 
HNSCC, cervical lymph nodes and distant metastasis (9).  The 
maximum standardized uptake value (SUVmax) is used as a 
quantitative parameter of FDG uptake, and PET / CT has been 
shown to be effective in detecting cervical lymph node metasta-
sis (10). However, false negative nodal metastasis assessed with 
PET / CT is still a problem in the pretreatment evaluation of 
patients with HNSCC (11). 
In the present retrospective study, clinical N0 patients with 
tongue cancer, who underwent elective supraomohyoid neck dis-
section at cervical levels of I-III were enrolled. We first examined 
the cutoff value of SUVmax in PET / CT to detect cervical lymph 
node metastasis in patients with clinically negative cervical 
lymph nodes of squamous cell carcinoma (SCC) of the tongue. 
Accordingly, we extracted a lymph node with the largest minor 
axis (< 10 mm) at each cervical level of I-III from preoperative 
CECT imaging in clinical N0 patients with tongue SCC. We 
then examined the correlation between the SUVmax of the 
lymph node extracted from a cervical level and postoperative 
histopathological findings of the resected lymph node at the 
corresponding cervical level. Finally, an attempt was made to 
identify a new diagnostic index to detect occult metastasis of 
cervical lymph nodes. For this purpose, we developed a com-
bined index : SUVmax of the largest lymph node in PET / CT by 
a weighting coefficient plus its maximum minor axis in CECT 
at a cervical level. The cutoff value of the combined index was 
examined to predict cervical metastatic lymph nodes in clinical 
N0 patients with tongue SCC using receiver operating charac-
teristic (ROC) analysis. 
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PATIENTS AND METHODS
Patients
A retrospective study was conducted at the Osaka Interna-
tional Cancer Institute Hospital. Among the 282 patients with 
tongue SCC who were previously untreated, 84 patients were 
evaluated as clinically N0 cervical stage using CECT between 
January 2005 and December 2013. In the preoperative assess-
ment of cervical lymph node metastasis, lymph nodes with a 
maximum minor axis of 10 mm or more with focal defect and / 
or rim enhancement in preoperative CECT were evaluated as 
clinically positive. In the present study, 57 clinical N0 patients 
with tongue SCC were enrolled. They underwent elective su-
praomohyoid neck dissection at cervical levels of I-III defined 
by the classification system of neck dissection (12) as a part of 
the primary surgical treatment according to “Japanese Clinical 
Practice Guideline for Head and Neck Cancer” made by the 
clinical practice guideline committee of Japan Society for Head 
and Neck Cancer. After surgery, neck resection specimens were 
histopathologically analyzed.  This study was approved by the 
Ethics Committee of the Osaka International Cancer Institute 
Hospital. 
CECT and PET / CT
All patients underwent both CECT with a slice thickness of 
1 mm and PET / CT within a month before surgery. 18F-FDG 
was intravenously injected at a dose of 3.7 mBq / kg after fasting 
for 5 h. PET / CT was performed 60 min later using SIEMENS 
Biograph Duo (Siemens Medical Solutions Inc., Knoxville, TN, 
USA) or Philips GEMINI GXL (Philips Medical Systems, Cleve-
land, OH, USA). 
Because it is impossible to determine the exact spatial correla-
tion between a resected lymph node and imaging of a lymph node 
on CECT or PET / CT in clinical N0 patients, we first extracted a 
lymph node with the largest minor axis (< 10 mm) at each cervi-
cal level of I-III from preoperative CECT imaging and measured 
the minor axis of the extracted lymph node in the present study. 
When a given cervical level contained at least one metastatic 
lymph node postoperatively, the largest lymph node at the cer-
vical level of CECT was considered to be histopathologically 
positive metastasis and its SUVmax of PET / CT was measured. 
When a given cervical level contained no metastatic lymph node 
postoperatively, the largest lymph node at the cervical level of 
CECT was considered to be histopathologically negative metas-
tasis and the SUVmax of PET / CT was measured.  Thereafter, 
the cutoff value of SUVmax in preoperative PET / CT to predict 
postoperative metastatic lymph nodes was determined using 
ROC analysis.
Combined index 
A new combined index : SUVmax of the largest lymph node in 
PET / CT by a weighting coefficient plus its maximum minor axis 
(< 10 mm) in CECT at a cervical level was developed. The cutoff 
values of the combined index to predict postoperative metastatic 
lymph nodes were evaluated using ROC analysis by changing 
the values of the weighting coefficient. After determining the 
weighting coefficient value to achieve the maximum area under 
the curve (AUC) of ROC, the optimal cutoff value of the com-
bined index was determined.
Statistical analysis
The ROC analysis and Student’s t-test were performed for 
statistical analysis using EZR (Saitama Medical Center, Jichi 
Medical University, Saitama, Japan). p < 0.05 was considered 
significant.
RESULTS
The enrolled 57 clinical N0 patients with tongue SCC con-
sisted of 34 males and 23 females with a mean age of 56.7 years 
(range 16-83 years). As per clinical T staging, T1 was 9, T2 was 
38 and T3 was 10 patients.  All patients are clinical N0 and M0 
(Table 1). Ipsilateral elective supraomohyoid neck dissection 
was performed on 57 sides of the neck at cervical levels of I-III. 
Among the 171 cervical levels that underwent neck dissection, 
22 cervical levels contained at least one metastatic lymph node, 
and the largest lymph node was extracted at the corresponding 
cervical levels of CECT. Among the remaining 149 cervical levels 
that contained no metastatic lymph node postoperatively, lymph 
nodes were extracted in 119 cervical levels of CECT. Accordingly, 
among 141 cervical levels that contained the extracted lymph 
nodes, of which the maximum minor axis was less than 10 mm 
in preoperative CECT, 22 cervical levels contained metastatic 
lymph nodes, while 119 cervical levels did not. 
The cutoff value of SUVmax of 2.0 obtained using ROC anal-
ysis predicted postoperative positive cervical levels from clinical 
N0 cervical levels in these patients with a sensitivity of 54.5% 
and a specificity of 78.2% (Table 2). The same cutoff value of 
SUVmax predicted pathological positive N stage in these clinical 
N0 patients with a sensitivity of 58.8% and a specificity of 62.5% 
(Table 3).
Then, we developed a new combined index of SUVmax of the 
extracted lymph node in PET / CT by a weighting coefficient plus 
its minor axis on CECT at a cervical level. The value of AUC 
was assessed using ROC analysis by changing the values of 
the weighting coefficient, and the maximum AUC of 0.750 was 
achieved at the weighting coefficient of 1.5 (Table 4). The mean 




    Male 34 59.6
    Female 23 40.4
  Age 56.7 y (16-83 y)
cT stage*
  T1 9 15.8
  T2 38 66.7
  T3 10 17.5




Positive level     Negative level   Total
Positive ( ≥ 2.0) 12 26 38 
Negative ( < 2.0) 10 93 103
Total 22 119 141
Table 3.　
SUVmax Histopathological status of the neck 
Positive     Negative     Total
Positive ( ≥ 2.0) 10 15 25 
Negative ( < 2.0) 7 25 32
Total 17 40 57
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values of the combined index with the weighting coefficient of 1.5 
in metastatic lymph nodes at 22 cervical levels were significant-
ly increased, compared to those at 119 negative cervical levels 
in these patients (t(139)= -4.6734, p < 0.05) (Fig. 1). The cutoff 
value of the combined index with the weighting coefficient of 1.5 
to predict metastatic cervical levels from clinical N0 cervical lev-
els was then assessed using ROC analysis and was determined 
to be 9.8.  
The cutoff value of the combined index of 9.8 predicted the 
postoperative positive cervical levels from clinical N0 cervical 
levels with a sensitivity of 68.2% and a specificity of 81.5% (Table 
5). The same cutoff value of the combination index predicted 
pathological positive N stage in these clinical N0 patients with a 
sensitivity of 82.4% and a specificity of 67.5% (Table 6).
 
DISCUSSION
CECT is still a standard tool for the diagnosis of cervical 
lymph node metastasis in patients with HNSCC. A meta-anal-
ysis reported that CECT showed a sensitivity of 81% (range 
68%–90%) and a specificity of 76% (range 62%–87%) for the 
diagnosis in such patients (13). PET / CT, a functional imaging 
of glucose metabolism with integrated CT is successively applied 
in the diagnosis, grading, staging and assessment of treatment 
response of HNSCC. A recent meta-analysis showed that it is 
also useful for the detection of nodal metastasis in HNSCC 
(10). A meta-analysis reported that PET / CT showed a sensi-
tivity of 79% (range 72%–85%) and a specificity of 86% (range 
83%–89%) for the diagnosis of cervical lymph node metastasis in 
patients with HNSCC (11). 
However, occult metastatic lymph nodes are the major prog-
nostic factor for survival in clinical N0 patients with HNSCC (4) 
and its prevalence was reported to be over 20 % of the patients 
with negative cervical stage evaluated using CECT (5-8). A me-
ta-analysis reported that PET / CT showed a sensitivity of only 
50% (range 37%–63%) and a specificity of 87% (range 76%–93%) 
for the diagnosis of cervical lymph node metastasis in clinical N0 
patients with HNSCC (10). In the present study, the cutoff SUV-
max of 2.0 in preoperative PET / CT showed a sensitivity of 54.5% 
and a specificity of 78.2% for the diagnosis of postoperative posi-
tive cervical levels from clinical N0 cervical levels of I-III, and a 
sensitivity of 58.8% and a specificity of 62.3% for the diagnosis of 
pathological positive N stage in clinical N0 patients with tongue 
SCC. Thus, PET / CT showed high specificity, but sensitivity was 
lower than desired in detecting nodal metastasis in clinical N0 
patients with oral cavity SCC (14, 15). 
The major question is whether to treat HNSCC patients with 
clinical N0 neck with elective neck dissection or to adopt ob-
servation / therapeutic neck dissection (16). A decision analysis 
showed that elective neck dissection is preferable over watchful 
waiting in patients with early stage oral tongue carcinoma with 
no clinical nodal metastases (17). However, another decision 
analysis showed that careful observation is preferable to pro-
phylactic neck dissection in oral cancer patients without clinical 
nodal metastases (18). A recent prospective, randomized, con-
trolled trial reported that elective neck dissection showed higher 
rates of overall, disease-free survival than watchful waiting 
followed by neck dissection for nodal relapse in patients with 
early stage oral SCC (19). Therefore, the decision of elective neck 
dissection still depends on the probability of occult neck metasta-
sis. To avoid unnecessary surgeries, patients who would have the 
greatest benefit from elective neck dissection should be selected. 
In the present study, we developed a new combined index of 
SUVmax of the lymph node in PET / CT by a weighting coeffi-
cient plus its minor axis in CECT for more accurate diagnosis 
of occult metastatic lymph nodes in clinical N0 patients with 
tongue SCC. Indeed, the combined index of SUVmax by the 
weighting coefficient of 1.5 plus the maximum minor axis with 
the optimal cutoff value of 9.8 showed better sensitivity of 68.2% 
and continued high specificity of 81.5% to predict postoperative 
positive cervical levels from clinical N0 levels of I-III. The same 
cutoff value of the combination index also predicted pathological 
positive N stage with better sensitivity of 82.4% and continued 
high specificity of 67.5% in clinical N0 patients. While PET / CT 
Table 4.　
Weighting coefficient 1 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 2.0
AUC* 0.747 0.747 0.748 0.748 0.748 0.750 0.747 0.745 0.745 0.744 0.743
*AUC : area under the curve
Figure 1.　Comparison of combined index values between positive 
and negative cervical levels. Columns and bars represent means ± 
S.D. of the mean values of the combined index with the weighting 
coefficient of 1.5 in lymph nodes of 22 metastatic positive cervical 
levels, and those of 119 negative cervical levels in clinical N0 patients 
with squamous cell carcinoma of tongue.      *p < 0.05. 
Table 5.　
Combined index Histopathological metastasis
Positive level     Negative level   Total
Positive ( ≥ 9.8) 15 22 37
Negative ( < 9.8) 7 97 104
Total 22 119 141
Table 6.　
Combined index  Histopathological status of the neck 
Positive     Negative     Total
Positive ( ≥ 9.8) 14 13 27
Negative ( < 9.8) 3 27 30
Total 17 40 57
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has low sensitivity and high specificity for the diagnosis of occult 
cervical lymph node metastasis (14, 15), the combined index that 
effectively combined SUVmax of lymph node in PET / CT with its 
minor axis in CECT increased the sensitivity and retained the 
high specificity for the diagnosis of cervical lymph node metasta-
sis in clinical N0 patients with tongue SCC. 
In the present retrospective study, among 27 tongue SCC 
patients with clinical N0 and positive combined index, histo-
pathologic metastasis in cervical lymph nodes was found in 52% 
(14 / 27) of patients. Because the decision analysis showed elec-
tive neck dissection is warranted when the probability of occult 
neck metastasis is more than 20% in clinical N0 patients with 
HNSCC (20), clinical N0 patients with a positive combined index 
may be good candidates for elective neck dissection for better 
prognosis of tongue SCC. 
The present study has several limitations including retro-
spective design and its small sample size. A selection bias (i.e., 
predilection of elective neck dissection for advanced T stages) 
may have influenced the results in the present study. Further 
prospective studies are required to prove the efficacy of the com-
bined index to evaluate occult lymph node metastasis in clinical 
N0 patients with tongue cancer.
CONCLUSION
In conclusion, the present study suggests that the combined 
index of functional SUVmax in PET / CT and morphological 
minor axis in CECT might be a promising tool to improve the 
diagnostic performance of occult nodal metastasis to select 
clinical N0 patients with tongue SCC preferable for elective neck 
dissection. 
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